The Scientist

» infectious disease

Most Recent

image: First Dengue Vax Approved

First Dengue Vax Approved

By | December 11, 2015

Mexico’s health ministry has OKed the vaccine for people between nine and 45 years old.

0 Comments

image: Lab-Made Coronavirus Triggers Debate

Lab-Made Coronavirus Triggers Debate

By | November 16, 2015

The creation of a chimeric SARS-like virus has scientists discussing the risks of gain-of-function research.

0 Comments

image: Week in Review: November 2–6

Week in Review: November 2–6

By | November 6, 2015

How Ebola hides from immune cells; gut microbes’ role in immunotherapy response; new mechanisms of hearing loss; butterflies use milkweed toxins to ward off predators

0 Comments

image: Toward a Universal Flu Vax

Toward a Universal Flu Vax

By | October 27, 2015

Adding an adjuvant to stimulate both innate and adaptive immunity, researchers boost the effectiveness of an influenza A vaccine in mice.

0 Comments

image: Weak Support for Malaria Vaccine

Weak Support for Malaria Vaccine

By | October 27, 2015

The World Health Organization recommends more pilot trials.

0 Comments

image: Infection Assistants

Infection Assistants

By | October 22, 2015

Parasite-derived exosomes boost Leishmania infection in mice. 

0 Comments

image: New Way to Edit Genes

New Way to Edit Genes

By | October 1, 2015

Researchers develop a more-efficient method for rewriting DNA that could hold therapeutic value for HIV and other diseases.

0 Comments

image: Treating Toxoplasmosis

Treating Toxoplasmosis

By | September 25, 2015

While one company hikes the price of an old drug to treat the parasitic infection, academic researchers report that an approved blood pressure medication could be just what the doctor ordered.

4 Comments

US Defense Department labs are the subject of inquiry following several safety breaches concerning the handling of deadly bacteria and virus strains. 

0 Comments

image: Dengue’s Downfall?

Dengue’s Downfall?

By | September 15, 2015

Researchers characterize a protein that could be key to the virus’s virulence—and to developing a vaccine against the mosquito-borne disease.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech